Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

141.74
Delayed Data
As of Oct 16
 -1.30 / -0.91%
Today’s Change
87.50
Today|||52-Week Range
144.34
+39.49%
Year-to-Date
Shire's New Formulation of Oncaspar Gets CHMP Recommendation
Oct 16 / Zacks.com - Paid Partner Content
Amicus Therapeutics (FOLD) Soars: Stock Adds 9.2% in Session
Oct 05 / Zacks.com - Paid Partner Content
AcelRx's Opioid Painkiller Dsuvia Gets CRL, Shares Plunge
Oct 13 / Zacks.com - Paid Partner Content
Palatin Technologies (PTN) in Focus: Stock Moves 13.2% Higher
Oct 05 / Zacks.com - Paid Partner Content
Forget Teva (TEVA), Buy These 5 Drug Stocks Instead
Oct 09 / Zacks.com - Paid Partner Content
Catabasis Pharmaceuticals (CATB) Surges: Stock Moves 7.2% Higher
Oct 04 / Zacks.com - Paid Partner Content
Ligand (LGND) Signs Deal to Acquire Crystal Bioscience
Oct 05 / Zacks.com - Paid Partner Content
MannKind (MNKD) in Focus: Stock Moves 7.8% Higher
Oct 03 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close143.04
Today’s open143.47
Day’s range140.78 - 143.66
Volume154,923
Average volume (3 months)245,986
Market cap$3.0B
Dividend yield--
Data as of 3:59pm ET, 10/16/2017

Growth & Valuation

Earnings growth (last year)-101.05%
Earnings growth (this year)+37.40%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+51.53%
P/E ratio373.0
Price/Sales19.42
Price/Book8.76

Competitors

 Today’s
change
Today’s
% change
PBHPrestige Brands Hold...-0.30-0.62%
GWPHGW Pharmaceuticals P...+0.11+0.10%
MDCOMedicines Co+0.17+0.49%
CBPOChina Biologic Produ...+0.92+1.15%
Data as of 4:02pm ET, 10/16/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$0.61
Annual revenue (last year)$109.0M
Annual profit (last year)-$2.4M
Net profit margin-2.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts